First Interstate Bank Continues to Hold Holding in Bristol (BMY); Cintas Corp. (CTAS) Holding Maintained by Caldwell & Orkin Inc

February 4, 2018 - By Ellis Scott

Caldwell & Orkin Inc increased its stake in Cintas Corp. (CTAS) by 28.76% based on its latest 2017Q3 regulatory filing with the SEC. Caldwell & Orkin Inc bought 3,842 shares as the company’s stock rose 2.03% with the market. The institutional investor held 17,202 shares of the apparel company at the end of 2017Q3, valued at $2.48 million, up from 13,360 at the end of the previous reported quarter. Caldwell & Orkin Inc who had been investing in Cintas Corp. for a number of months, seems to be bullish on the $17.23B market cap company. The stock decreased 2.03% or $3.36 during the last trading session, reaching $161.82. About 446,660 shares traded. Cintas Corporation (NASDAQ:CTAS) has risen 32.38% since February 4, 2017 and is uptrending. It has outperformed by 15.68% the S&P500.

First Interstate Bank increased its stake in Bristol (BMY) by 6.3% based on its latest 2017Q3 regulatory filing with the SEC. First Interstate Bank bought 7,030 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 118,681 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $7.57 million, up from 111,651 at the end of the previous reported quarter. First Interstate Bank who had been investing in Bristol for a number of months, seems to be bullish on the $103.90B market cap company. The stock increased 1.08% or $0.68 during the last trading session, reaching $63.48. About 11.72M shares traded or 105.23% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 4, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

First Interstate Bank, which manages about $465.11 million US Long portfolio, decreased its stake in Blackrock Fund Advisors (EFA) by 12,683 shares to 33,511 shares, valued at $2.30 million in 2017Q3, according to the filing. It also reduced its holding in Target Corp (NYSE:TGT) by 8,567 shares in the quarter, leaving it with 14,905 shares, and cut its stake in Vanguard (VNQ).

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. On Wednesday, October 25 the stock rating was maintained by Citigroup with “Buy”. Berenberg downgraded Bristol-Myers Squibb Company (NYSE:BMY) on Thursday, August 11 to “Hold” rating. Piper Jaffray upgraded the shares of BMY in report on Monday, August 24 to “Underweight” rating. The company was maintained on Monday, August 14 by Cowen & Co. The firm has “Buy” rating by Citigroup given on Wednesday, October 18. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Sell” rating by BMO Capital Markets on Sunday, July 23. On Friday, October 28 the stock rating was maintained by Deutsche Bank with “Hold”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Tuesday, March 15. Deutsche Bank maintained the stock with “Hold” rating in Monday, July 17 report. The company was maintained on Wednesday, April 5 by BMO Capital Markets.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Cambiar Invsts Ltd holds 733,890 shares or 0.73% of its portfolio. Quantitative Inv Mgmt Ltd Liability Co reported 12,200 shares. Retirement Systems Of Alabama holds 0.42% in Bristol-Myers Squibb Company (NYSE:BMY) or 1.25 million shares. Hancock, Mississippi-based fund reported 7,382 shares. Edge Wealth Ltd Com owns 0.01% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 770 shares. 4,703 were reported by Btr Cap. Bailard has invested 0.31% in Bristol-Myers Squibb Company (NYSE:BMY). Voloridge Investment Management Ltd Llc holds 0.15% or 107,904 shares. Commonwealth Bancorp Of Aus reported 73,384 shares. The Michigan-based Comerica Bancorporation has invested 0.27% in Bristol-Myers Squibb Company (NYSE:BMY). Lombard Odier Asset Mngmt (Europe) holds 20,301 shares or 0.07% of its portfolio. Ntv Asset Lc reported 35,667 shares stake. Huntington Retail Bank stated it has 0.63% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Gideon Advisors Incorporated has 0.21% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 3,379 shares. Bankshares holds 0.11% in Bristol-Myers Squibb Company (NYSE:BMY) or 5,589 shares.

Since September 6, 2017, it had 1 insider buy, and 2 insider sales for $646,385 activity. Samuels Theodore R. II had bought 4,000 shares worth $249,187. Caldarella Joseph C had sold 9,340 shares worth $560,400.

Caldwell & Orkin Inc, which manages about $128.52 million and $98.28 million US Long portfolio, decreased its stake in General Dynamics (NYSE:GD) by 2,400 shares to 6,300 shares, valued at $1.30 million in 2017Q3, according to the filing. It also reduced its holding in Costco Wholesale Corp (NASDAQ:COST) by 3,600 shares in the quarter, leaving it with 2,400 shares, and cut its stake in Vanguard S/T Tips Etf (VTIP).

Since August 11, 2017, it had 0 buys, and 3 insider sales for $2.37 million activity. 2,000 shares were sold by Adolph Gerald S, worth $267,380. $1.99M worth of Cintas Corporation (NASDAQ:CTAS) was sold by Holloman James Phillip.

Among 15 analysts covering Cintas (NASDAQ:CTAS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Cintas had 42 analyst reports since August 14, 2015 according to SRatingsIntel. Robert W. Baird upgraded the shares of CTAS in report on Wednesday, August 17 to “Outperform” rating. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, December 21 report. On Wednesday, August 17 the stock rating was maintained by Nomura with “Buy”. The rating was upgraded by Barclays Capital on Wednesday, August 17 to “Overweight”. The rating was downgraded by Instinet to “Neutral” on Tuesday, June 27. The firm has “Buy” rating given on Tuesday, October 31 by Robert W. Baird. The rating was maintained by Morgan Stanley with “Underweight” on Tuesday, July 25. The rating was maintained by Morgan Stanley with “Underweight” on Wednesday, September 27. On Tuesday, June 27 the stock rating was downgraded by Nomura to “Hold”. The company was maintained on Tuesday, September 26 by Stifel Nicolaus.